SCHEMBL6803114

SCHEMBL6803114

CN(C(C(=O)NO)C1CCN(C(=O)N2CCOCC2)CC1)S(=O)(=O)c1ccc(-c2ccc(F)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADAMTS7 Q9UKP4 4/20 0.59
ADAMTS5 Q9UNA0 4/20 0.59
MMP13 P45452 6/20 0.47
MMP1 P03956 5/20 0.47
MMP2 P08253 3/20 0.47
MMP3 P08254 3/20 0.47
MMP8 P22894 3/20 0.47
MMP7 P09237 2/20 0.47
MMP9 P14780 2/20 0.47
PKM P14618 1/20 0.46
ADAMTS4 O75173 1/20 0.46
ADAM17 P78536 1/20 0.46
ADAMTS1 Q9UHI8 1/20 0.46
LMNA P02545 2/20 0.40
DPP4 P27487 1/20 0.40
AKR1C3 P42330 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6294208 0.89 MMP13 (0.61) ADAMTS7ADAMTS5MMP13MMP1MMP2
SCHEMBL6290479 0.83 MMP13 (0.61) ADAMTS7ADAMTS5MMP13MMP1MMP2
SCHEMBL6291178 0.82 MMP13 (0.54) ADAMTS7ADAMTS5MMP13MMP1MMP2
SCHEMBL6804554 0.80 MMP13 (0.64) ADAMTS7ADAMTS5MMP13MMP1MMP2
SCHEMBL7534479 0.80 MMP1 (0.46) ADAMTS7ADAMTS5MMP13MMP1MMP2
SCHEMBL7534476 0.80 MMP1 (0.46) ADAMTS7ADAMTS5MMP13MMP1MMP2
SCHEMBL6810494 0.79 MMP13 (0.59) ADAMTS7ADAMTS5MMP13MMP1MMP2
SCHEMBL6290466 0.79 MMP13 (0.69) ADAMTS7ADAMTS5MMP13MMP1MMP2
SCHEMBL7531009 0.77 ADAMTS7 (0.51) ADAMTS7ADAMTS5MMP13MMP1MMP2
SCHEMBL7531012 0.77 ADAMTS7 (0.51) ADAMTS7ADAMTS5MMP13MMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040127498-A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors THE PROCTER & GAMBLE COMPANY 2004-07-01 US claimed
US-20030139414-A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors THE PROCTER & GAMBLE COMPANY 2003-07-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139414-A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors MME, MMP2, MMP9 ADAMTS7 90/4885ADAMTS5 87/4885MMP13 38/4885
US-20040127498-A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors MME, MMP2, MMP9 ADAMTS7 90/4885ADAMTS5 87/4885MMP13 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.